# The Role of Cannabinoids in Dermatology > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabinoids-in-dermatology-benefits-skin-conditions/ > **Published:** 2022-05-10T16:03:25-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:16:38-04:00 > **Clinical Summary:** Explore cannabinoids in dermatology and their therapeutic benefits for treating itch and other skin conditions with medical cannabis. --- Historically, [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) has been used most extensively to treat [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), anorexia, and nausea in advanced cancer patients undergoing chemotherapy. Recently, its therapeutic effects against many other conditions have been actively researched, with treating itch-related dermatologic conditions emerging as a promising application. Chronic kidney disease-associated pruritus (CKD-aP) is chronic itching that occurs in 20%-50% of patients with advanced or end-stage renal disease and causes long-term pain. Physicians have studied the benefits of a cream containing endogenous cannabinoids – compounds similar to components of cannabis but produced naturally by the human body in CKD-aP patients on hemodialysis. In this study, topical application of the cream twice daily completely eliminated itching in 38% of the patients, in addition to alleviating dryness in 81% after only 3 weeks. Moreover, the cream was well tolerated. Other dermatologists have demonstrated the benefits of an emollient cream with palmitoylethanolamide (PEA) in patients experiencing intense itchy spots and thickened skin spots resulted from itching. They found that PEA, which stimulates anandamide – an endogenous cannabinoid, reduced itch by 86.4% and was also well tolerated by the study participants. In summary, these clinical studies provided compelling evidence of the benefits and safety of [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) and cannabinoids in treating itch. Although not as well understood, their applications in several other dermatologic conditions including skin rashes, inflammations, and skin cancers are also under active research with promising results [More access here](https://cedclinic.com/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabinoids in Children: Medical Evidence Reviewed](https://cedclinic.com/cannabinoids-in-pediatric-medicine-evidence-reviewed/) Review the [clinical evidence](https://cedclinic.com/academic-partnerships-cannabis-research/) on cannabinoids use in pediatric care and their safety profile. [Read More](https://cedclinic.com/cannabinoids-in-pediatric-medicine-evidence-reviewed/) [Topical Cannabis for AIMSS: Medical Cannabis Evidence](https://cedclinic.com/topical-cannabinoid-application-feasibility-aimss-treatment/) Explore evidence supporting topical cannabis treatments for arthritis-related symptoms. [Learn More](https://cedclinic.com/topical-cannabinoid-application-feasibility-aimss-treatment/) [Use of a Synthetic Cannabinoid in a Correctional Population](https://cedclinic.com/nabilone-synthetic-cannabinoid-ptsd-insomnia-pain/) Study on [synthetic cannabinoids](https://cedclinic.com/synthetic-cannabinoid-parkinsons-trial-ser-252-funding/) for PTSD-related insomnia, nightmares, and [chronic pain management](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/). [Explore Study](https://cedclinic.com/nabilone-synthetic-cannabinoid-ptsd-insomnia-pain/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=The%20Role%20of%20Cannabinoids%20in%20Dermatology&url=https%3A%2F%2Fcedclinic.com%2Fcannabinoids-in-dermatology-benefits-skin-conditions%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabinoids-in-dermatology-benefits-skin-conditions%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=The%20Role%20of%20Cannabinoids%20in%20Dermatology%20https%3A%2F%2Fcedclinic.com%2Fcannabinoids-in-dermatology-benefits-skin-conditions%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).